Search research articles
Contact Us
Filters
Showing results (581-590 of 620) with videos related to
Page
of 62
Sort By:
Global Mental Health (Cambridge, England)
|
January 9, 2023
Feasibility of a school-based mental health program implementation to improve the status of depression and quality of life of mothers of children with autism spectrum disorders in urban Bangladesh: MENTHOL study
Aliya Naheed, Md Saimul Islam, Meredith B Brooks, et al.
Health Services Research
|
January 14, 2020
Trends in smoking documentation rates in safety net clinics
Stephen P Fortmann, Steffani R Bailey, Neon B Brooks, et al.
Multiple Sclerosis and Related Disorders
|
November 29, 2017
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Multiple Sclerosis and Related Disorders
|
May 30, 2018
Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Platelets
|
November 29, 2017
Endothelial alterations in a canine model of immune thrombocytopenia
Dana N LeVine, Rachel E Cianciolo, Keith E Linder, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 30, 2018
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial
Gustavo E Velásquez, Meredith B Brooks, Julia M Coit, et al.
Plos One
|
January 13, 2017
Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability
Marjory B Brooks, James R Turk, Abraham Guerrero, et al.
The Journal of Infectious Diseases
|
April 16, 2025
Impact of pharmacogenetics on pharmacokinetics of first-line anti-tuberculosis drugs in the HIRIF trial
E A Mackay, G Platt, C A Peloquin, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors
Guoxin Zhu, Scott E Conner, Xun Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 1, 2004
Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors
Rima S Al-awar, James E Ray, Kyle A Hecker, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 620) with videos related to
Sort By:
Page
of 62
Global Mental Health (Cambridge, England)
|
January 9, 2023
Feasibility of a school-based mental health program implementation to improve the status of depression and quality of life of mothers of children with autism spectrum disorders in urban Bangladesh: MENTHOL study
Aliya Naheed, Md Saimul Islam, Meredith B Brooks, et al.
Health Services Research
|
January 14, 2020
Trends in smoking documentation rates in safety net clinics
Stephen P Fortmann, Steffani R Bailey, Neon B Brooks, et al.
Multiple Sclerosis and Related Disorders
|
November 29, 2017
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Multiple Sclerosis and Related Disorders
|
May 30, 2018
Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]
Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Platelets
|
November 29, 2017
Endothelial alterations in a canine model of immune thrombocytopenia
Dana N LeVine, Rachel E Cianciolo, Keith E Linder, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 30, 2018
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial
Gustavo E Velásquez, Meredith B Brooks, Julia M Coit, et al.
Plos One
|
January 13, 2017
Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability
Marjory B Brooks, James R Turk, Abraham Guerrero, et al.
The Journal of Infectious Diseases
|
April 16, 2025
Impact of pharmacogenetics on pharmacokinetics of first-line anti-tuberculosis drugs in the HIRIF trial
E A Mackay, G Platt, C A Peloquin, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors
Guoxin Zhu, Scott E Conner, Xun Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 1, 2004
Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors
Rima S Al-awar, James E Ray, Kyle A Hecker, et al.
Page
of 62